Voloridge Investment Management, LLC Astrazeneca PLC Transaction History

Voloridge Investment Management, LLC

$25.9 Billion
Q4 2024

A detailed history of Voloridge Investment Management, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Voloridge Investment Management, LLC holds 196,661 shares of AZN stock, worth $14.8 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

196,661

Previous 448,417 56.14%

Holding current value

$14.8 Million

Previous $34.9 Million 63.12%

% of portfolio

0.05%

Previous 0.13%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$63.2 - $79.58 $15.9 Million - $20 Million	-251,756 Reduced 56.14%	196,661 $12.9 Million
Q3 2024 Nov 14, 2024	BUY	$76.67 - $87.62 $34.4 Million - $39.3 Million	448,417 New	448,417 $34.9 Million
Q1 2024 May 15, 2024	BUY	$61.03 - $69.57 $36.5 Million - $41.6 Million	597,291 Added 237.49%	848,793 $57.5 Million
Q4 2023 Feb 14, 2024	BUY	$61.89 - $69.28 $699,852 - $783,418	11,308 Added 4.71%	251,502 $16.9 Million
Q3 2023 Nov 14, 2023	SELL	$64.85 - $71.7 $14 Million - $15.4 Million	-215,422 Reduced 47.28%	240,194 $16.3 Million
Q2 2023 Aug 14, 2023	SELL	$69.91 - $75.81 $32.2 Million - $34.9 Million	-460,556 Reduced 50.27%	455,616 $32.6 Million
Q1 2023 May 15, 2023	BUY	$63.15 - $71.6 $2.99 Million - $3.39 Million	47,295 Added 5.44%	916,172 $63.6 Million
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $22.8 Million - $29.7 Million	420,967 Added 93.98%	868,877 $58.9 Million
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $23.6 Million - $60.3 Million	444,234 Added 12084.71%	447,910 $24.6 Million
Q2 2022 Aug 15, 2022	BUY	$59.26 - $71.14 $217,839 - $261,510	3,676 New	3,676 $243,000
Q1 2022 May 16, 2022	SELL	$55.72 - $67.12 $2.98 Million - $3.59 Million	-53,492 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$54.02 - $63.83 $2.89 Million - $3.41 Million	53,492 New	53,492 $3.12 Million
Q2 2021 Aug 16, 2021	SELL	$48.42 - $60.18 $55.8 Million - $69.3 Million	-1,152,052 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$47.16 - $54.44 $91.2 Million - $105 Million	-1,933,710 Reduced 62.67%	1,152,052 $57.3 Million
Q4 2020 Feb 16, 2021	BUY	$48.52 - $58.02 $150 Million - $179 Million	3,085,762 New	3,085,762 $154 Million
Q3 2020 Nov 16, 2020	SELL	$53.07 - $61.1 $11 Million - $12.7 Million	-207,692 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$43.1 - $55.31 $1.86 Million - $2.39 Million	43,205 Added 26.27%	207,692 $11 Million
Q1 2020 May 15, 2020	SELL	$37.79 - $51.33 $8.06 Million - $11 Million	-213,404 Reduced 56.47%	164,487 $7.35 Million
Q4 2019 Feb 14, 2020	BUY	$42.46 - $50.46 $1.64 Million - $1.95 Million	38,691 Added 11.41%	377,891 $18.8 Million
Q3 2019 Nov 14, 2019	BUY	$40.12 - $45.47 $4.51 Million - $5.12 Million	112,534 Added 49.65%	339,200 $15.1 Million
Q2 2019 Aug 14, 2019	BUY	$37.28 - $41.68 $2.72 Million - $3.04 Million	72,841 Added 47.35%	226,666 $9.36 Million
Q1 2019 May 15, 2019	SELL	$35.49 - $43.02 $2.22 Million - $2.69 Million	-62,604 Reduced 28.93%	153,825 $6.22 Million
Q4 2018 Feb 14, 2019	BUY	$36.86 - $41.49 $7.98 Million - $8.98 Million	216,429 New	216,429 $8.22 Million
Q3 2018 Nov 14, 2018	SELL	$34.76 - $39.72 $8.54 Million - $9.76 Million	-245,777 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$34.55 - $37.05 $5.53 Million - $5.93 Million	-159,968 Reduced 39.43%	245,777 $8.63 Million
Q1 2018 May 15, 2018	BUY	$32.97 - $36.63 $7.41 Million - $8.24 Million	224,844 Added 124.29%	405,745 $14.2 Million
Q4 2017 Feb 14, 2018	BUY	$32.09 - $34.78 $5.81 Million - $6.29 Million	180,901	180,901 $6.28 Million

Others Institutions Holding AZN

# of Institutions

1,358

Shares Held

512M

Call Options Held

6.08M

Put Options Held

4.44M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $234B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.

Account

Voloridge Investment Management, LLC Astrazeneca PLC Transaction History